Le. Mather et al., THE SYSTEMIC AND CEREBRAL KINETICS OF THIOPENTAL IN SHEEP - ENANTIOMERIC ANALYSIS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 291-297
Thiopental is used as a racemate (rac-thiopental). Enantiomeric pharma
cokinetic differences could therefore influence the onset and duration
of anesthesia of rac-thiopental. We studied the systemic and cerebral
kinetics of R(+)- and S(-)-thiopental in five adult ewes after a 2-mi
n intravenous infusion of 500 mg rac-thiopental sodium. Systemic kinet
ic values were determined from the time course of concentrations in ar
terial plasma; cerebral kinetic values were deduced from the time cour
se of the concentration differences between arterial and superior sagi
ttal sinus blood plasma. Enantiomeric differences were found in both s
ites, with the (R:S) ratio of thiopental enantiomer blood concentratio
ns initially being greater than or equal to 1 then decreasing to <1 af
ter approximately 60 min. This is consistent with the finding of the m
ean total body clearance of R(+)-thiopental being 17% (SD 12%) greater
than that of S(-)-thiopental (P = .04). Sagittal sinus plasma concent
rations of both enantiomers followed closely behind those in arterial
plasma and this is consistent with facile bidirectional exchange of th
iopental between plasma and brain. No significant differences were fou
nd between enantiomers in the rates of brain influx or efflux. Onset a
nd regression of anesthesia occurred while the enantiomer blood concen
trations were similar. Hence published pharmacokinetic-pharmacodynamic
models of the onset of thiopental effects probably are not significan
tly compromised by neglecting the enantiomeric duality of thiopental,
but models based on its elimination kinetics could be compromised if e
nantiomeric differences are neglected.